Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Kenvue (NYSE:KVUE), the consumer care spinoff of Johnson & Johnson’s (JNJ), traded higher on Friday after The Financial Times ...

Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue , sources familiar with the matter ...

Investors seeking low-priced stocks in this expensive market have three stocks to consider. LyondellBasell (LYB) is steady at ...

Kenvue Inc. closed 6.21% short of its 52-week high of $24.46, which the company reached on November 26th.

With a market cap of $42.7 billion, Kenvue Inc. (KVUE) operates as a consumer health company in the United States and ...

Dubai, UAE – Kenvue, the world’s largest pure-play consumer health company by revenue and maker of Listerine, Nicorette, and ...

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft ...

The Belgian antitrust regulator sanctioned some of the largest purveyors of over-the-counter medicines, the latest effort by ...

Kenvue (KVUE) announced a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital ...

Kenvue Inc., has announced a five-year collaboration with Microsoft which aims to transform digital operations through ...

The board of Kenvue Inc. ( NYSE:KVUE ) has announced that it will pay a dividend of $0.205 per share on the 28th ...